Willingness to pay in arthritis: A Danish contribution

Rheumatology

Volumn 39, Issue 7, 2000, Pages 791-799

  Slothuus, U ^a   Brooks, R G ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cost benefit analysis; Economic appraisal; Rheumatoid arthritis; TNF blockade; Willingness to pay

Indexed keywords

ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DENMARK; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TECHNIQUE;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COST-BENEFIT ANALYSIS; DENMARK; DRUG THERAPY; FEASIBILITY STUDIES; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033943856     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.7.791     Document Type: Article

References (39)

1. The economics of arthritis.
2. Health economics as an aspect of health outcome: Basic principles and application in rheumatoid arthritis
3. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: A literature review
4. Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis
5. A summary of economic evaluations published in the field of rheumatology and related disciplines
6. Economic evaluation of nimesulide versus diclofenac in the treatment of osteoarthritis in Greece
7. Cost effectiveness analysis of drug therapies for rheumatoid arthritis
8. Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use?
9. In- and out-patient rehabilitation in rheumatoid arthritis. A controlled, open, longitudinal, cost-effectiveness study
10. Reduced utilization and cost of primary care clinic visits resulting from self-care education for patients with osteoarthritis of the knee
11. Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis
12. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip
13. Cost-effectiveness and quality of life in knee arthroplasty
14. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: Randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone
15. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy
16. Economic consequences of the progression of rheumatoid arthritis in Sweden
17. Cost-benefit analysis of patients treated at a rheumatism centre
18. Cost-benefit analysis
19. Cost-benefit analysis of synovectomy of the knee
20. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor
21. A method for documenting the economic efficacy of multiple-component interventions designed to enhance functional and social status
22. The value of life
23. Willingness to pay as a measure of health benefits
24. Feasibility of willingness-to-pay measurement in chronic arthritis
25. Willingness to pay and accept risks to cure chronic disease
26. Determining the cost of a clinical intervention through the use of shadow pricing
27. Health care contingent valuation studies: A review and classification of the literature
28. Ministry of Health
29. Recent advances in the methods of cost-benefit analysis in health care: Matching the art to the science
30. National Oceanic and Atmospheric Administration (NOAA). Report of the NOAA Panel on Contingent Valuation
31. Health status questionnaires
32. Quality of life measures
33. Outcome measures, pooled index and quality of life estimates in rheumatoid arthritis
34. Does economic evaluation have anything to offer the rheumatologist?
35. Report of the OMERACT task force on economic evaluation. Outcome measures in rheumatology